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Female pattern hair loss (FPHL) is a common hair disorder of the central scalp. The clinical change in hair density,
related to a change in the hair cycle and miniaturization of the hair follicle, is generally considered to be potentially
reversible. However, there is now evidence of a permanent hair loss that develops in a subset of women with FPHL.
The presence of a perifollicular lymphohistiocytic inﬁltrate and ﬁbrosis is seen without follicular drop-out in
biopsies of women with FPHL and with a notable follicular drop-out in a cicatricial form of this condition (heretofore
called cicatricial pattern hair loss) as well as in ﬁbrosing alopecia in a pattern distribution, currently classiﬁed as a
subset of lichen planopilaris. The potential relationship of these conditions as well as frontal ﬁbrosing alopecia and
central centrifugal cicatricial alopecia, two other conditions of permanent hair loss seen primary in women, is
discussed.
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Cicatricial alopecia is a poorly understood group of
disorders, generally only diagnosed by dermatologists and
then usually only late in the process. The primary cicatricial
alopecias all initially involve some form of inflammation in
the region of the follicular isthmus (and thus also the bulge
area) plus/minus inflammation in the infundibular area
(Headington, 1996; Whiting, 2001a; Bergfeld and Elston,
2003). Clinical inflammation, if present, may appear in the
early, but not the final stages and primarily in those types of
cicatricial alopecia that involve the infundibulum such as
lichen planopilaris and chronic lupus erythematosus. In the
late stage of cicatricial alopecia, regardless of cause, there
is loss of follicular ostia. In only some types of cicatricial
alopecia, including the majority of primary cicatricial
alopecia, is the other hallmark of this general process
present, i.e. epidermal atrophy. Because of the lack of
clinical atrophy and/or histological evidence of a ‘‘scar’’ in
all patients who experience loss of the follicular apparatus,
the umbrella term ‘‘permanent alopecia’’ (Bergfeld and
Elston, 1994) may be more appropriate than ‘‘cicatricial
alopecia’’ when discussing the breadth of these disorders.
It is very apparent that cicatricial, or permanent, alopecia
may have abundant histological evidence of inflammation
without any clinical sign of inflammation. For example,
chronic lupus erythematosus rarely may present with
patches of hair loss without evidence of clinical inflamma-
tion and yet there is usually a heavy perifollicular lympho-
cytic infiltrate in the dermis (Bergfeld and Elston, 2003).
Pseudopelade of Brocq presents as flesh-toned patches of
hair loss with little, if any, clinical inflammation (Braun-Falco
et al, 1986; Brocq et al, 1905; Gay Prieto, 1955), but at least
in the early stages, may display histological evidence of
inflammation (Newton et al, 1987). The patches of hair loss
in the latter condition typically do not show significant
atrophy but primarily loss of follicular ostia. Permanent
alopecia may also present without any clinical or histologi-
cal inflammation as illustrated by the genetic disorder of
atrichia with papular lesions (Zlotogorski et al, 2001). In this
condition, the first pelage is normal but the hair is unable to
transition from telogen to anagen after the first telogen and
thus the hair loss becomes permanent. Loss of follicular
ostia follows but not atrophy.
There are other types of hair loss, generally considered
fully reversible, that may, in certain situations, also become
permanent. For example, long-standing alopecia totalis/
universalis (Whiting, 2001a, b) or extensive long-standing
baldness in male pattern hair loss (MPHL) (Headington and
Novak, 1984), may develop follicular drop-out in the
affected areas. The affected scalp in these situations is
usually devoid of any visible hair, including vellus hair, and
has loss of follicular ostia on clinical exam. Neither of these
conditions, however, typically has clinical signs of scalp
inflammation preceding the permanent hair loss.
Female pattern hair loss (FPHL) is a condition character-
ized clinically by a decrease in hair density in the central
scalp and histologically by miniaturization of some follicles
and an increased percentage of hair in telogen in the
affected area (Olsen, 2001). ‘‘Patterning’’ in FPHL is much
less obvious than in MPHL but may be one of three
patterns: in order of frequency of occurrence, they are
frontal accentuation (‘‘Christmas tree’’ pattern), diffuse
central or vertex/frontal (male pattern) (Olsen, 2001). MostThere are no conflicts of interest to disclose.
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patients with FPHL do not require a biopsy for confirmation
of the diagnosis, however, as the clinical findings of a
decrease in density of the central scalp hair with sparing of
the occiput, no patches of hair loss, frontal accentuation of
hair loss (if present), negative hair pull on the sides and back
of the scalp and a normal appearing scalp are usually
sufficient to make the diagnosis (Olsen, 1999). Although
generally considered a fully reversible form of alopecia,
there is histological evidence of inflammation and fibrosis in
70% of patients with FPHL (Whiting, 1998) and inflammation
in MPHL has been shown to correlate with decreased
responsiveness to topical minoxidil (Whiting, 1993).
Scant attention until recently has been paid to this
component of FPHL, i.e. the perifollicular inflammation and
fibrosis that may affect the potential for regrowth in this
disorder (Whiting, 1998). In the last 4 y, however, a distinct
type of cicatricial alopecia typified by inflammation and
fibrosis with hair loss in the distribution of typical FPHL has
been reported i.e., ‘‘fibrosing alopecia in a pattern distribu-
tion’’ (FAPD) (Zinkernagel and Trueb, 2000). In addition, a
common form of cicatricial alopecia that occurs in African
American women i.e., central centrifugal cicatricial alopecia
(CCCA) (Olsen et al, 2003), presents in the same area of the
scalp as FPHL and also is typified by a perifollicular
lymphocytic infiltrate. Frontal fibrosing alopecia is a recently
described form of permanent alopecia whose histology is
similar to FAPD but whose distribution of loss occurs only
in the frontotemporoparietal scalp (Kossard, 1994), not
a distribution of hair loss typical of FPHL but one that
overlaps with the frontal loss seen in some forms of MPHL.
The purpose of this paper is to review the potential and
established associations between FPHL and permanent
alopecia that occur in this same scalp distribution.
Fibrosing Alopecia in a Pattern
Distribution (FAPD)
Reported by Zinkernagel and Trueb (2000), FAPD generally
presents as accelerated hair loss in the central scalp of
subjects with underlying pattern hair loss. Females are more
commonly affected than men, the latter who all have had
preceding male pattern baldness. Clinically, FAPD presents
with perifollicular erythema plus/minus follicular hyperker-
atosis and loss of follicular orifices in the central scalp. On
biopsy, there is a lymphohistiocytic infiltrate around the
isthmus and infundibular region of the hair follicle, con-
centric perifollicular lamellar fibrosis, sebaceous gland loss,
and a lymphocytic interface dermatitis with destruction of
the basal keratinocytes (Zinkernagel and Trueb, 2000).
These histological findings are identical to that seen in
lichen planopilaris and thus despite its location and milieu in
which it develops, FAPD is currently classified as a subtype
of lichen planopilaris (Kossard, 1994; Sperling et al, 2000).
The net result is a reduction in the number of terminal hair
follicles by either the underlying miniaturization process of
pattern hair loss or by replacement of follicles by fibrous
tracts.
Anti-androgens in two women and finasteride in one man
with FAPD have been reported to halt the progression of the
hair loss (Zinkernagel and Trueb, 2000). In the case of the
male patient, the finasteride also decreased the clinical
inflammation. These results speak to a potential androgen-
related etiology in this disorder. That an antiandrogen alone
should decrease scalp inflammation is an interesting
observation that needs further follow-up.
Frontal Fibrosing Alopecia (FFA)
Frontal fibrosing alopecia is a condition that was first
described by Kossard (1994). This type of hair loss almost
exclusively presents in postmenopausal women although
a few reports in younger women have been published
(Faulkner et al, 2002; Bergfeld and Elston, 2003). A gradual
recession of not only the frontal but also the temporoparietal
hairline follows perifollicular erythema with or without
associated follicular keratosis. The hair loss progresses
backward to about 8 cm maximum (Kossard et al, 1997) (Fig
1). This recession occurs in a distribution of a male pattern
of frontal scalp hair loss (Norwood type IIa or Hamilton type
IV pattern of hair loss) (Olsen, 2003) although the degree of
parietal hair loss is unusual for even MPHL. Moreover,
perifollicular eythema is not typical for frontal recession in
MPHL.
Venning and Dawber (1988) noted that 37% of post-
menopausal women have temporal recession but did not
note any cicatricial process. Hamilton (1951) described
frontal hair loss in women with androgenetic alopecia
including frontotemporal recession extending to 3 cm
posterior to a coronal plane between the two external
auditory meatus . Ludwig’s (1977) pattern of diffuse central
hair loss in women, on the other hand, always included
retention of the frontal fringe of hair.
Frontal fibrosing alopecia is characterized histologically
by a lymphocytic infiltrate around the isthmus and infun-
dibular region of the hair follicles as well as concentric
perifollicular lamellar fibrosis (Kossard, 1994). This histology
is identical to that of FAPD but has overlapping features with
‘‘pseudopelade’’ and CCCA as well (Kossard et al, 1997).
Moreover, the presence of frontal fibrosing alopecia in
Figure1
Frontal fibrosing alopecia. (Reprinted with permission from Bergfeld
and Elston (2003) Courtesy of Dr Steven Kossard.)
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patients with FAPD (Zinkernagel and Trueb, 2000) raises the
question of whether these two conditions, with histological
overlap, may be one fork in the road for FPHL towards a
cicatricial alopecia. FFA is currently classified as a variant of
lichen planopilaris (Olsen et al, 2003). Of note, Tosti et al,
(2005) has reported that frontal fibrosing alopecia, like
FAPD, may also respond to finasteride.
Cicatricial Pattern Hair Loss (CPHL)
The author has coined this term to describe the histologi-
cally confirmed presence of a permanent alopecia in the
distribution of FPHL but without the perifollicular erythema
or follicular hyperkeratosis seen in FAPD (Fig 2). The typical
patient with cicatricial pattern hair loss is over 40 y of age
and has small (pencil eraser size) areas of ‘‘focal atrichia’’
(Olsen, 2001). Focal atrichia appears to be a relatively
specific sign of this late onset, clinically obvious FPHL (E. A.
Olsen, unpublished information). Scalp biopsy shows a
perifollicular lymphohistiocytic infiltrate surrounding the
isthmus, sebaceous gland loss, and concentric lamellar
fibrosis. What component of this hair loss is reversible and
which therapies might be most useful have yet to be
determined. Despite the negative results of finasteride in a
general population of postmenopausal women with ‘‘andro-
genetic alopecia’’ (Price et al, 2000), many of whom had
minimal clinical evidence of hair thinning, it is possible that
patients with CPHL, like those of FAPD, may respond to
antiandrogens or to finasteride.
Central Center CCCA
This common type of hair loss was first reported under the
term ‘‘hot comb alopecia’’ by LoPresti et al (1968). This
particular hair loss occurs almost exclusively in African
Americans, most commonly in African American women. As
it became apparent that African American men may also be
effected as well as those individuals who have not used
hot combs (a method by which oiled or greased hair
is straightened with a heated iron) (Sperling and Sau, 1992;
Sperling et al, 1994; Headington, 1996), the terminology
evolved to ‘‘follicular degeneration syndrome’’ per Sperling
and Sau (1992) and more recently to CCCA (Olsen et al,
2003), the descriptive term adopted by the North American
Hair Research Society (NAHRS). Whether hair grooming
methods specific to the African American culture, such as
hot combs, relaxers, tight braids, heavy extensions, and a
variety of oils and pomades, could cause or at least
contribute to the hair loss remains an unsubstantiated
assumption.
The hair loss in CCCA begins in the central midline scalp
and is slowly progressive centrifugally (Fig 3). The condition
may progress to a Hamilton Norwood Type VI or VII pattern
or may only involve the top of the scalp. Inflammation may
or may not be obvious clinically. Perifollicular erythema or
follicular keratoses are not typical findings. Histologically, a
perivascular and perifollicular lymphocytic infiltrate, con-
centric lamellar fibrosis, sebaceous gland loss as well as
premature disintegration of the internal root sheath is typical
(Whiting, 2001a, b). Granulomatous inflammation secondary
to follicular rupture may also be seen (Sperling and Sau,
1992). Recently, these histological findings have been given
Figure 2
Cicatricial pattern hair loss. No inflammation of perifollicular papules
preceded the loss of follicles in the central scalp.
Figure3
Central centrifugal cicatricial alopecia.
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the moniker of ‘‘pseudopelade’’ which, unlike the entity
of pseudopelade described by Brocq, does not typically
have the clinical counterpart of discrete non-inflammatory
patches of hair loss.
No effective therapy for CCCA has been definitively
identified. Discontinuation of the use of hot combs, relaxers,
and/or excessive heat, all factors that have been identified
as possibly causing this condition, has, in most cases, not
led to cessation of progressive hair loss. Whether hair care
products that are used to moisturize the hair and scalp
could be etiological factors has never been addressed. Both
bacterial and fungal scalp infections need to be searched
for and treated as these may be contributing factors.
Although anti-inflammatory medications such as topical
steroids and/or systemic antibiotics may slow hair loss in
many cases, this author has not found them to be uniform-
ly effective treatments. Well-controlled clinical trials are
needed to address these issues.
Although it is clear that MPHL is less common and less
extensive in men of African versus European descent (Smith
and Wells, 1964; Setty, 1970), there appears to be a further
decrease in the incidence of FPHL in African American
compared with Caucasian women (E. A Olsen, unpublished
data). Potential explanations for this disparity include a
difference in the hereditary potential for pattern hair loss in
African American women compared with Caucasian wo-
men, different hormonal characteristics in the two races, an
intrinsically different clinical presentation of FPHL in African
American women or another hair loss process super-
imposed on FPHL in African American women that
obliterates the usual non-scarring presentation. The possi-
bility that women with CCCA could have underlying FPHL,
albeit with a degree of superimposed inflammation and
fibrosis not typically seen in Caucasian women with FPHL,
deserves consideration (Olsen, 2003). A controlled trial of
antiandrogens or 5 aR inhibitors early in the process may be
of value to help sort out whether there is any androgen
relationship to this process.
Discussion and Conclusions
FPHL, despite the frequency in the general population,
remains a poorly understood disorder. At the present time,
in this author’s view, FPHL should be thought of as a clinical
phenotype of central hair loss that may be caused by (1) a
hereditary androgen-driven condition that presents in young
women, the female counterpart of MPHL, (2) an age-related
condition that may or may not have a hereditary component
and is likely related to a confabulation of hormonal changes
resulting from the menopause, adrenopause and somato-
pause that are temporally related, (3) a non-hereditary
androgen driven process that may occur in any age patient.
Up until recently, the view was that the central Ludwig
pattern of hair loss was the dominant clinical presentation of
FPHL and women who presented with this pattern of hair
loss, regardless of age, had an androgen-driven genetic
process also called androgenetic alopecia (Frieden and
Price, 1986). This viewpoint was first challenged in 1999
when it was suggested that thinking of this presentation of
hair loss first by age of onset and second by whether or not
hyperandrogenism is present and using the term ‘‘FPHL’’
versus androgenetic alopecia might help to unravel the
conflict between the concept of androgen etiology and lack
of response of all patients to antiandrogens (Olsen, 2001). In
this author’s view, separating out the FPHL that begins in
middle age from that which develops post-puberty through
early in the third decade, and considering all hormonal
factors that are changing in concert at the time of the hair
loss, may be the most fruitful path to eventually unraveling
the cause of this most common type of FPHL. We will likely
find that the concept of ‘‘senescent alopecia’’ as presented
by Kligman (1988) overlaps with this latter type of late-onset
FPHL.
The assumption that FPHL is always a potentially
reversible disorder also needs reassessment based on the
histological findings of at least a moderate lymphocytic
inflammation/fibrosis in 435% of patients with pattern hair
loss compared with 9% of controls and the decrease in
number of total follicles in affected patients (Whiting, 1998).
The presence of a lymphocytic cicatricial alopecia in an
FPHL distribution in both Caucasian females (FAPD and
CPHL) and African American females (CCCA) begs the
question of whether the inflammation in FPHL is a primary
or secondary component of the hair loss and how it relates
to the cicatricial component. The fact that antiandrogens or
5 aR inhibitors have been shown in limited cases to
decrease the inflammation and/or the clinical findings in
FAPD and frontal fibrosing alopecia begs consideration of
the potential role of androgens in the development of the
inflammatory reaction in the scalp.
Other potential factors to explore in the etiology of the
inflammation seen in women with a central pattern of hair
loss typical of FPHL are hair care and scalp products and
grooming practices. Certainly Caucasian as well as African
American women are exposed to chemicals placed on the
hair and scalp (permanents and/or relaxers) and scalp heat
(hot curlers, hot combs, handheld, and/or turban dryers)
that may cause tissue damage and inflammation and
contribute to hair loss. The effect of these common
practices on the etiology of any permanent hair loss seen
in FPHL needs to be sorted out. That the portion of the
follicle in the bulge region, where a population of follicular
stem cells lie, may be a particularly attractive target for
inflammatory cytokines has been shown in patients with
graft versus host disease where there appears to be some
selective targeting of the undifferentiated stem cells of
the hair follicle (Sale et al, 1994). Furthermore, IL-1a, a
proinflammatory cytokine, has been shown to inhibit hair
growth and fiber production in whole organ culture albeit
with interindividual differences (Harmon and Nevins, 1993
and Mahe, Buan, Billoni et al, 1996).
In conclusion, FPHL is a clinical phenotype with most
likely various etiologies all of which are potentially over-
lapping. Although classified as a non-scarring or reversible
disorder, FPHL has the potential for transitioning to a
permanent type of hair loss. The role of inflammation in
FPHL as a precursor to permanent hair loss (CPHL) or even
to the reversible component of the hair loss needs further
exploration and the role that androgens and external factors
play in the development of inflammation evaluated. In
particular, whether the condition of CCCA represents a
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more severe variant of CPHL in African Americans needs
consideration.
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